These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11576767)

  • 21. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fabric-staining properties and washability of a novel liposomal dithranol formulation.
    Saraswat A; Agarwal R; Kaur I; Katare OP; Kumar B
    J Dermatolog Treat; 2002 Sep; 13(3):119-22. PubMed ID: 12227874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The response of uninvolved skin of patients with psoriasis to single and repeated applications of dithranol cream: an immunohistochemical assessment.
    Swinkels OQ; Prins M; van Vlijmen-Willems IM; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2002; 15(6):385-92. PubMed ID: 12476012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dithranol in a cream preparation: disperse or dissolve?
    Prins M; Swinkels OQ; Bouwhuis S; de Gast MJ; Bouwman-Boer Y; van der Valk PG; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2000; 13(5):273-9. PubMed ID: 10940817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loading of water-insoluble celastrol into niosome hydrogels for improved topical permeation and anti-psoriasis activity.
    Meng S; Sun L; Wang L; Lin Z; Liu Z; Xi L; Wang Z; Zheng Y
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110352. PubMed ID: 31306831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis.
    Moghddam SR; Ahad A; Aqil M; Imam SS; Sultana Y
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():789-97. PubMed ID: 27612773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation and evaluation of niosomal nasal drug delivery system of folic acid for brain targeting.
    Ravouru N; Kondreddy P; Korakanchi D; Haritha M
    Curr Drug Discov Technol; 2013 Dec; 10(4):270-82. PubMed ID: 23863098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes.
    Nasr M; Mansour S; Mortada ND; Elshamy AA
    J Microencapsul; 2008 Oct; 25(7):499-512. PubMed ID: 18608811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposomal hydrogel formulation for transdermal delivery of pirfenidone.
    Jose A; Mandapalli PK; Venuganti VV
    J Liposome Res; 2016; 26(2):139-47. PubMed ID: 26114208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flurbiprofen-loaded ethanolic liposome particles for biomedical applications.
    Paliwal S; Tilak A; Sharma J; Dave V; Sharma S; Verma K; Tak K; Reddy KR; Sadhu V
    J Microbiol Methods; 2019 Jun; 161():18-27. PubMed ID: 30951793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
    Abdelbary AA; AbouGhaly MH
    Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models.
    Tabbakhian M; Tavakoli N; Jaafari MR; Daneshamouz S
    Int J Pharm; 2006 Oct; 323(1-2):1-10. PubMed ID: 16837150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). II. Clinical comparison of dithranol and butantrone sticks with special reference to side effects.
    Brandt H
    Acta Derm Venereol; 1987; 67(1):55-61. PubMed ID: 2436415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of liposomes and niosomes on skin permeation of enoxacin.
    Fang JY; Hong CT; Chiu WT; Wang YY
    Int J Pharm; 2001 May; 219(1-2):61-72. PubMed ID: 11337166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
    Guinedi AS; Mortada ND; Mansour S; Hathout RM
    Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
    Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
    Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis.
    Sminkels OQ; Prins M; Veeniiuis RT; De Boo T; Gerritsen MJ; Van Der Wilt GJ; Van De Kerkhof PC; Van Der Valk PG
    Eur J Dermatol; 2004; 14(3):159-65. PubMed ID: 15246941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation and Characterization of a 3D-Printed Cryptotanshinone-Loaded Niosomal Hydrogel for Topical Therapy of Acne.
    Wang Z; Liu L; Xiang S; Jiang C; Wu W; Ruan S; Du Q; Chen T; Xue Y; Chen H; Weng L; Zhu H; Shen Q; Liu Q
    AAPS PharmSciTech; 2020 May; 21(5):159. PubMed ID: 32476076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dithranol: An Insight into its Novel Delivery Cargos for Psoriasis Management.
    Kadian V; Kumar S; Saini K; Kakkar V; Rao R
    Curr Drug Res Rev; 2020; 12(2):82-96. PubMed ID: 32484107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
    Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
    Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.